Moors & Cabot, Inc. Organon & Co. Transaction History

Moors & Cabot, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$16.59 - $23.77 $41,392 - $59,306	-2,495 Reduced 16.9%	12,267 $212,000
Q2 2023 Aug 09, 2023	BUY	$19.27 - $24.63 $41,758 - $53,373	2,167 Added 17.21%	14,762 $307,000
Q1 2023 May 04, 2023	SELL	$21.42 - $32.08 $7,475 - $11,195	-349 Reduced 2.7%	12,595 $296,000
Q4 2022 Feb 09, 2023	SELL	$23.31 - $28.61 $2,284 - $2,803	-98 Reduced 0.75%	12,944 $361,000
Q4 2022 Feb 06, 2023	SELL	$23.31 - $28.61 $9,976 - $12,245	-428 Reduced 3.18%	13,042 $364,000
Q3 2022 Nov 07, 2022	SELL	$23.4 - $34.25 $12,308 - $18,015	-526 Reduced 3.76%	13,470 $315,000
Q2 2022 Aug 08, 2022	SELL	$31.66 - $38.9 $22,700 - $27,891	-717 Reduced 4.87%	13,996 $472,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $17,995 - $23,261	591 Added 4.18%	14,713 $514,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $47,764 - $61,858	-1,666 Reduced 10.55%	14,122 $430,000
Q3 2021 Dec 08, 2021	BUY	$28.63 - $35.64 $22,560 - $28,084	788 Added 5.25%	15,788 $519,000
Q3 2021 Nov 05, 2021	SELL	$28.63 - $35.64 $26,740 - $33,287	-934 Reduced 5.86%	15,000 $18,000
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $453,322 - $605,492	15,934 New	15,934 $482,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.